Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Assessment of Clinical Presentation and Prognosis of Patients with Acute-On-Chronic Liver Failure among Participants Admitted in the Intensive Care Units of Tertiary Care Hospitals in Pakistan

View through CrossRef
Background: Acute chronic liver failure can be defined as a disease that is characterized as spontaneous deterioration of hepatic liver decompensation that was previously suffering from chronic liver conditions along with one or more than one organ failure extra hepatically which will consequently result in a risk of mortality. This study will focus on assessing the clinical and biochemical disease, cause, and outcomes of acute on chronic liver failure. Methodology: This cross-sectional study was conducted on 60 acute-on-chronic liver failure patients in the department of Internal Medicine, Holy Family Hospital, Rawalpindi and Lahore General Hospital of Pakistan from July 2021 to December 2021. Participants recruited for the study were presented with chronic liver disease with cirrhosis. Participants were divided into two groups, following admission into ward and the ICU. The participants were further divided into three groups according to acute on chronic liver failure. Patients were assessed for clinical outcomes and biochemical profiles of participants. Results: The outcomes of this study showed the primary etiology of chronic liver disease. The majority of participants forming group 2 of ICU had etiology of viral hepatitis C with a prevalence of 90% (n =27). The prevalence of viral hepatitis C etiology among participants was 96.7% with a number of participants being 29 of 30 in group 1. The most common aggravating factor for liver failure was bacterial origin in both ICU and ward with a prevalence of 80% and 76% respectively in both groups (n =24, n =23). The most common aggravating factor was observed to be a spontaneous bacterial infection in group two with a prevalence of 70% (n =21), whereas group one participants showed a prevalence of 63.3% (n= 19). The most common cause of organ failure among acute on chronic failure was most highly seen in the renal system with a prevalence of 60% among group 2 participants (n =18), whereas the incidence in group 1 was seen in 25 participants with a prevalence of 83.8%. Conclusion: The study concludes that the most common cause of the chronic liver disease is hepatitis c virus followed by hepatitis B virus. The most common aggravating factor for acute on chronic liver failure was spontaneous bacterial infection followed by a chest infection. The most common organ failure seen in participants was renal failure followed by cerebral failure. Keywords: Clinical Presentation, Prognosis, Acute-on-chronic liver failure, Intensive care unit
Title: Assessment of Clinical Presentation and Prognosis of Patients with Acute-On-Chronic Liver Failure among Participants Admitted in the Intensive Care Units of Tertiary Care Hospitals in Pakistan
Description:
Background: Acute chronic liver failure can be defined as a disease that is characterized as spontaneous deterioration of hepatic liver decompensation that was previously suffering from chronic liver conditions along with one or more than one organ failure extra hepatically which will consequently result in a risk of mortality.
This study will focus on assessing the clinical and biochemical disease, cause, and outcomes of acute on chronic liver failure.
Methodology: This cross-sectional study was conducted on 60 acute-on-chronic liver failure patients in the department of Internal Medicine, Holy Family Hospital, Rawalpindi and Lahore General Hospital of Pakistan from July 2021 to December 2021.
Participants recruited for the study were presented with chronic liver disease with cirrhosis.
Participants were divided into two groups, following admission into ward and the ICU.
The participants were further divided into three groups according to acute on chronic liver failure.
Patients were assessed for clinical outcomes and biochemical profiles of participants.
Results: The outcomes of this study showed the primary etiology of chronic liver disease.
The majority of participants forming group 2 of ICU had etiology of viral hepatitis C with a prevalence of 90% (n =27).
The prevalence of viral hepatitis C etiology among participants was 96.
7% with a number of participants being 29 of 30 in group 1.
The most common aggravating factor for liver failure was bacterial origin in both ICU and ward with a prevalence of 80% and 76% respectively in both groups (n =24, n =23).
The most common aggravating factor was observed to be a spontaneous bacterial infection in group two with a prevalence of 70% (n =21), whereas group one participants showed a prevalence of 63.
3% (n= 19).
The most common cause of organ failure among acute on chronic failure was most highly seen in the renal system with a prevalence of 60% among group 2 participants (n =18), whereas the incidence in group 1 was seen in 25 participants with a prevalence of 83.
8%.
Conclusion: The study concludes that the most common cause of the chronic liver disease is hepatitis c virus followed by hepatitis B virus.
The most common aggravating factor for acute on chronic liver failure was spontaneous bacterial infection followed by a chest infection.
The most common organ failure seen in participants was renal failure followed by cerebral failure.
Keywords: Clinical Presentation, Prognosis, Acute-on-chronic liver failure, Intensive care unit.

Related Results

Cometary Physics Laboratory: spectrophotometric experiments
Cometary Physics Laboratory: spectrophotometric experiments
<p><strong><span dir="ltr" role="presentation">1. Introduction</span></strong&...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
The Role of the Judiciary in Constitutional Interpretation in Pakistan
The Role of the Judiciary in Constitutional Interpretation in Pakistan
This study examines the evolving role of the judiciary in Pakistan in interpreting the Constitution, exploring how the courts have come to terms with their position as the primary ...
EVALUATION AND COMPARISON OF LIVER MARKERS IN ACUTE LIVER FAILURE VS CHRONIC LIVER FAILURE IN DISTRICT FAISALABAD: A CROSS-SECTIONAL STUDY
EVALUATION AND COMPARISON OF LIVER MARKERS IN ACUTE LIVER FAILURE VS CHRONIC LIVER FAILURE IN DISTRICT FAISALABAD: A CROSS-SECTIONAL STUDY
Background: Liver failure is a life-threatening clinical condition resulting from the inability of the liver to maintain its metabolic, synthetic, and detoxification functions. Acu...
Pediatric Pilonidal Sinus Disease: A Single-Center Cohort Study of Clinical and Surgical Outcomes
Pediatric Pilonidal Sinus Disease: A Single-Center Cohort Study of Clinical and Surgical Outcomes
Abstract Introduction: Pilonidal sinus disease is increasingly recognized in the pediatric population, yet evidence on its clinical characteristics and surgical outcomes in childre...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

Back to Top